Oncolytics Biotech (ONCY) Tops Q2 EPS by 2c

Oncolytics Biotech (NASDAQ: ONCY) reported Q2 EPS of ($0.05), $0.02 better than the analyst estimate of ($0.07).

For earnings history and earnings-related data on Oncolytics Biotech (ONCY) click here.

You May Also Be Interested In

• Midday movers: Meta, IBM, Caterpillar fall; Chipotle rises
• First BanCorp (FBP) PT Raised to $21 at Keefe, Bruyette & Woods
• Esquire Financial Holdings, Inc. (ESQ) Tops Q1 EPS by 3c